Nuo Therapeutics, Inc. SEC filings AURX
Nuo Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 8, 2005. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, new debt, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 30, 2025 | — |
| DEF 14A | Proxy statement | Oct 30, 2025 | Dec 16, 2025 |
| DEFA14A | Additional proxy material | Oct 20, 2022 | — |
| DEF 14A | Proxy statement | Oct 20, 2022 | Dec 2, 2022 |
| DEF 14C | Information statement | Apr 27, 2022 | Apr 27, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2019 | Apr 17, 2019 |
| DEF 14A | Proxy statement | Aug 28, 2018 | Sep 28, 2018 |
| PRE 14A | Preliminary proxy statement | Aug 15, 2018 | Aug 15, 2018 |
| PRE 14A | Preliminary proxy statement | Dec 13, 2017 | Dec 12, 2017 |
| DEF 14A | Proxy statement | Apr 28, 2017 | Apr 28, 2017 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2017 | Apr 17, 2017 |
| PRE 14C | Form pre 14c | Apr 3, 2017 | Apr 3, 2017 |
| DEF 14C | Information statement | Nov 25, 2016 | Nov 28, 2016 |
| DEF 14A | Proxy statement | Oct 1, 2014 | Nov 12, 2014 |
| PRE 14A | Preliminary proxy statement | Sep 19, 2014 | Sep 19, 2014 |
| DEF 14A | Proxy statement | May 2, 2014 | Jun 9, 2014 |
| PRE 14A | Preliminary proxy statement | Apr 21, 2014 | Apr 21, 2014 |
| DEF 14A | Proxy statement | Nov 12, 2013 | Dec 16, 2013 |
| DEF 14A | Proxy statement | Apr 26, 2013 | May 31, 2013 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2013 | Apr 15, 2013 |
| DEF 14A | Proxy statement | Aug 20, 2012 | Sep 28, 2012 |
| DEF 14A | Proxy statement | Apr 16, 2012 | May 18, 2012 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2012 | Apr 3, 2012 |
| DEF 14A | Proxy statement | Aug 22, 2011 | Sep 30, 2011 |
| DEF 14A | Proxy statement | Aug 25, 2010 | Oct 1, 2010 |
| DEF 14A | Proxy statement | May 27, 2010 | Jun 30, 2010 |
| PRE 14A | Preliminary proxy statement | May 14, 2010 | May 14, 2010 |
| DEF 14A | Proxy statement | Aug 11, 2009 | Sep 18, 2009 |
| DEF 14A | Proxy statement | Aug 11, 2008 | Sep 19, 2008 |
| DEF 14A | Proxy statement | Aug 13, 2007 | Sep 21, 2007 |
| DEF 14A | Proxy statement | Sep 22, 2006 | Nov 3, 2006 |
| DEF 14A | Proxy statement | Sep 16, 2005 | Nov 21, 2005 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AURX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1091596
- Former names
- Nuo Therapeutics, Inc (until Dec 23, 2014); CYTOMEDIX INC (until Oct 8, 2014); AUTOLOGOUS WOUND THERAPY INC (until Apr 10, 2000); AUTOLOGOUS WOUND TRERAPY INC (until Mar 23, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.